Overview
GHRP-6 Overview
GHRP-6 is a synthetic hexapeptide with the sequence His-D-Trp-Ala-Trp-D-Phe-Lys-NH2. It came out of early work on met-enkephalin analogs, but it shows no opioid receptor activity. Two D-amino acids in its chain set it apart from naturally occurring peptides and are associated with resistance to enzymatic degradation.
GHRP-6 is a first-generation growth hormone-releasing peptide and one of the first synthetic agonists of the growth hormone secretagogue receptor (GHS-R1a), later identified as the receptor for ghrelin. In preclinical and in vitro models, researchers study it for acute, pulsatile growth hormone release from pituitary somatotroph cells and for GHS-R1a activation in the hypothalamus, including feeding-related signaling pathways. It is also used to examine how GHS-R1a and GHRH receptor signaling interact when co-activated with GHRH analogs, along with somatostatin tone and binding to the scavenger receptor CD36. Further laboratory work has examined downstream IGF-1, Akt, and Bcl-2 signaling in rodent tissue, and myoblast differentiation in cell culture.
Each lot is made by solid-phase peptide synthesis, third-party tested, and supplied with a Certificate of Analysis.
| Sequence | His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 |
|---|---|
| Sequence length | 6 amino acids |
| Also known as | Growth hormone-releasing peptide 6, growth hormone-releasing hexapeptide, SKF-110679 |
| Molecular formula | C46H56N12O6 |
| Molecular weight | 873.0 g/mol |
| CAS number | 87616-84-0 |
| Form | Lyophilized powder |
| Purity | >99% by HPLC, per COA |
| Storage | -20°C, sealed, dry, and protected from light |
Certificate of Analysis
| Date | Lot | Certificate |
|---|---|---|
| GHRP-6 - 10 mgFeb 19, 2026 | 260212GP53 | View COA |